Voyager Therapeutics, Inc.
VYGR
Revenue
6.28M
▼-18.35M▼-74.51%
3 Months ChangeAssets
393.05M
▼-32.99M▼-7.74%
3 Months ChangeLiabilities
93.29M
▼-2.44M▼-2.55%
3 Months ChangeFree Cash Flow
56.63M
▼-66.43M▼-53.98%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-05
Form 8-K
ID: 0001104659-24-097152
2024-08-06
Form 10-Q
ID: 0001558370-24-011073
2024-08-06
Form 8-K
ID: 0001558370-24-011071
2024-06-13
Form 8-K
ID: 0001104659-24-071048
2024-06-06
Form 8-K
ID: 0001104659-24-069063
2024-05-16
Form 8-K
ID: 0001104659-24-062257
2024-05-13
Form 10-Q
ID: 0001558370-24-007953
2024-05-13
Form 8-K
ID: 0001558370-24-007951
2024-04-02
Form 8-K
ID: 0001104659-24-042502
2024-03-13
Form 8-K
ID: 0001104659-24-033726